PACS Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PACS Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.29B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.09B | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | $935.71M | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $919.84M | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | $3.11B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.42B | Nov 19, 2025 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.29B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.09B | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | $935.26M | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $919.41M | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | $3.11B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.40B | Nov 19, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $191.54M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $55.76M | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | ($31.88M) | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $34.82M | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | $112.87M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $150.50M | Nov 19, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $309.60M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $123.07M | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | ($37.18M) | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $65.31M | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | $207.77M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $229.36M | Nov 19, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $404.22M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $367.34M | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | $93.52M | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $58.75M | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | $63.70M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $92.62M | Nov 19, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.58B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.24B | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | $3.93B | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $3.86B | Nov 19, 2025 |
| FY2024 | Dec 31, 2023 | $3.51B | Nov 19, 2025 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.63B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.53B | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | $3.39B | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $3.74B | Nov 19, 2025 |
| FY2024 | Dec 31, 2023 | $3.41B | Nov 19, 2025 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $946.77M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $709.55M | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | $536.84M | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $113.67M | Nov 19, 2025 |
| FY2024 | Dec 31, 2023 | $96.13M | Nov 19, 2025 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.79M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $60.79M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $59.02M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $55.22M | Nov 19, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $309.58M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $118.04M | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | $65.22M | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $113.34M | Nov 19, 2025 |
| FY2024 | Dec 31, 2023 | $96.00M | Nov 19, 2025 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $197.02M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $157.67M | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | $73.37M | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | $81.21M | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | $73.42M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $58.27M | Nov 19, 2025 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $353.21M | Feb 27, 2026 |
| FY2024 | Dec 31, 2024 | $411.91M | Nov 19, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | 0 | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Nov 19, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | 0 | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Nov 19, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 156.62M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 155.18M | Feb 27, 2026 |
| FY2024 | Jun 30, 2024 | 152.40M | Nov 19, 2025 |
| FY2024 | Mar 31, 2024 | 128.72M | Nov 19, 2025 |
| FY2024 | Dec 31, 2023 | 128.72M | Nov 19, 2025 |